Yu–Fu Su

423 total citations
16 papers, 298 citations indexed

About

Yu–Fu Su is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yu–Fu Su has authored 16 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yu–Fu Su's work include Lung Cancer Diagnosis and Treatment (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Yu–Fu Su is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Esophageal Cancer Research and Treatment (3 papers). Yu–Fu Su collaborates with scholars based in Taiwan and United Kingdom. Yu–Fu Su's co-authors include Chu‐Yen Chien, Shyun-Yeu Liu, Chia‐Chen Hsu, Yi‐Shing Shieh, Chi‐Fu Chiang, Ting‐Ting Chao, Wen‐Yen Huang, Shine‐Gwo Shiah, Kuo‐Chou Chiu and Chien-Hsing Lee and has published in prestigious journals such as PLoS ONE, Scientific Reports and Oncotarget.

In The Last Decade

Yu–Fu Su

14 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu–Fu Su Taiwan	9	121	74	72	63	61	16	298
Heqing Li China	12	167 1.4×	92 1.2×	103 1.4×	27 0.4×	67 1.1×	18	396
Josephine Chou United States	9	246 2.0×	100 1.4×	85 1.2×	28 0.4×	29 0.5×	24	640
Joo Yong Park South Korea	12	157 1.3×	123 1.7×	155 2.2×	21 0.3×	77 1.3×	28	456
Anne V. Herdman United States	8	184 1.5×	142 1.9×	100 1.4×	16 0.3×	51 0.8×	10	483
Da‐Lei Zhou China	11	153 1.3×	122 1.6×	31 0.4×	66 1.0×	49 0.8×	24	352
Guillaume B. Cardin Canada	11	184 1.5×	40 0.5×	25 0.3×	51 0.8×	40 0.7×	23	342
Lei Cheng China	13	173 1.4×	216 2.9×	102 1.4×	38 0.6×	89 1.5×	39	526
Xiaojun Liu China	10	129 1.1×	99 1.3×	65 0.9×	68 1.1×	51 0.8×	30	365
Lorenz Kadletz Austria	13	113 0.9×	241 3.3×	179 2.5×	46 0.7×	45 0.7×	34	456
Heladio P. Ibarguen United States	8	132 1.1×	117 1.6×	31 0.4×	25 0.4×	63 1.0×	10	310

Countries citing papers authored by Yu–Fu Su

Since Specialization

Citations

This map shows the geographic impact of Yu–Fu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu–Fu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu–Fu Su more than expected).

Fields of papers citing papers by Yu–Fu Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu–Fu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu–Fu Su. The network helps show where Yu–Fu Su may publish in the future.

Co-authorship network of co-authors of Yu–Fu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yu–Fu Su. A scholar is included among the top collaborators of Yu–Fu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu–Fu Su. Yu–Fu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Chen, Po‐Huang, Cheng‐Hsiang Lo, Yu–Fu Su, et al.. (2025). Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysis. EClinicalMedicine. 87. 103432–103432.

Liao, Guo‐Shiou, Yu–Fu Su, Wen‐Yu Chuang, et al.. (2024). Xenogeneic platelet-rich plasma lotion for preventing acute radiation dermatitis in patients with breast cancer undergoing radiotherapy: An open-label, randomized controlled trial. JPRAS Open. 43. 271–279.

Lo, Cheng‐Hsiang, Yu–Fu Su, Jen-Fu Yang, et al.. (2024). Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell Carcinoma. JCO Precision Oncology. 8(8). e2400555–e2400555. 1 indexed citations

Su, Yu–Fu, Chun‐Shu Lin, Shuang‐En Chuang, et al.. (2023). MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathway. Journal of Dental Sciences. 19(1). 428–437. 5 indexed citations

Huang, Wen‐Yen, et al.. (2022). Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data. Japanese Journal of Clinical Oncology. 52(9). 992–1000. 3 indexed citations

Huang, Wen‐Yen, Cheng‐Hsiang Lo, Jen-Fu Yang, et al.. (2022). Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy. Biomedicines. 10(3). 597–597. 11 indexed citations

Hsu, Chia‐Chen, Kuo‐Yang Tsai, Yu–Fu Su, et al.. (2020). α7-Nicotine acetylcholine receptor mediated nicotine induced cell survival and cisplatin resistance in oral cancer. Archives of Oral Biology. 111. 104653–104653. 20 indexed citations

Hsu, Chia‐Chen, Yu–Fu Su, Kuo‐Yang Tsai, et al.. (2020). Gamma synuclein is a novel nicotine responsive protein in oral cancer malignancy. Cancer Cell International. 20(1). 300–300. 11 indexed citations

Chen, Yu-Jen, Chun‐Shu Lin, Kuen‐Tze Lin, et al.. (2019). Review of current perspectives on low-energy X-ray intraoperative radiotherapy in early stage breast cancer. 3. 12–12. 2 indexed citations

10.

Su, Yu–Fu, et al.. (2018). Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer. Scientific Reports. 8(1). 12877–12877. 8 indexed citations

11.

Chiang, Chi‐Fu, Ting‐Ting Chao, Yu–Fu Su, et al.. (2017). Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling. Oncotarget. 8(13). 20706–20718. 141 indexed citations

12.

Huang, Wen‐Yen, Chun‐Shu Lin, Yu–Fu Su, et al.. (2017). Risk of second primary malignancies among patients with prostate cancer: A population-based cohort study. PLoS ONE. 12(4). e0175217–e0175217. 21 indexed citations

13.

Lin, Chun‐Shu, Hsing‐Lung Chao, Wen‐Yen Huang, et al.. (2017). Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study. Radiotherapy and Oncology. 123(3). 394–400. 26 indexed citations

14.

Lo, Cheng‐Hsiang, Chun‐Shu Lin, Hsing‐Lung Chao, et al.. (2017). Stereotactic Ablative Radiotherapy for Patients with Unresectable or Medically Inoperable Cholangiocarcinoma. Tumori Journal. 103(3). 236–241. 8 indexed citations

15.

Jen, Yee‐Min, Ching‐Liang Ho, Ming–Shen Dai, et al.. (2012). Improved outcomes in buccal squamous cell carcinoma. Head & Neck. 35(1). 65–71. 12 indexed citations

16.

Huang, Wen‐Yen, Yee‐Min Jen, Chang‐Ming Chen, et al.. (2010). Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer. Radiation Oncology. 5(1). 37–37. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact